Expressive Wealth »

Neurocrine Biosciences shares owned by Expressive Wealth

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Expressive Wealth from 13F filings

Historical chart of Expressive Wealth investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Expressive Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Expressive Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $208k 1.4k 147.02

More positions owned by Expressive Wealth

Spdr Gold Tr Gold Shs (GLD)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
NVIDIA Corporation (NVDA)
Ishares Tr S&p 500 Grwt Etf (IVW)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)

View all positions for Expressive Wealth

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Vestal Point Capital
Millennium Management

View all funds holding Neurocrine Biosciences